• Publication

Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria

Deborah A. Bilder, J. Kay Noel, Erin R. Baker, William Irish, Yinpu Chen, Markus J. Merilainen, Suyash Prasad, and Barbara J. Winslow

• Publication

International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria

Ania C. Muntau, Darius J. Adams, Amaya Bélanger-Quintana, Tatiana V. Bushueva, Roberto Cerone, Yin-Hsiu Chien, Ana Chiesa, Turgay Coşkun, Javier de las Heras, François Feillet, Rachel Katz, Florian Lagler, Flavia Piazzon, Fran Rohr, Francjan J. van Spronsen, Paula Vargas, Gisela Wilcox, Kaustuv Bhattacharya

• Publication

Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis

Susan Waisbren, Barbara K. Burton, Annette Feigenbaum, Laura L. Konczal, Joshua Lilienstein, Shawn E. McCandless, Richard Rowell, Amarilis Sanchez-Valle, Kaleigh B. Whitehall, Nicola Longo

• Publication

Long-term safety and efficacy of sapropterin: The PKUDOS registry experience

Nicola Longo, Georgianne L. Arnold, Gabriella Pridjian, Gregory M. Enns, Can Ficicioglu, Susan Parker, Jessica L. Cohen-Pfeffer

• Publication

Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria

Nicola Longo, MD, PhD, David Dimmock, MD, Harvey Levy, MD, Krista Viau, PhD, RD, Heather Bausell, RD, LDN, Deborah A. Bilder, MD, Barbara Burton, MD, Christel Gross, RN, Hope Northrup, MD, Fran Rohr, MS, RD, Stephanie Sacharow, MD, Amarilis Sanchez-Valle, MD, Mary Stuy, MD, Janet Thomas, MD, Jerry Vockley, MD, PhD, Roberto Zori, MD and Cary O. Harding, MD

• Publication

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data

Melissa Lah, Keziah Cook, Dumingu Aparna Gomes, Stephanie Liu, Nadia Tabatabaeepour, Noam Kirson, Er Chen, Kristin Lindstrom, Kaleigh Bulloch Whitehall, Joost Van Backle, Barbara K. Burton

• Publication

Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics

Darius Adams, Hans C. Andersson, Heather Bausell, Kea Crivelly, Caroline Eggerding, Melissa Lah, Joshua Lilienstein, Kristin Lindstrom, Markey McNutt, Joseph W. Ray, Heather Saavedra, Stephanie Sacharow, Danielle Starin, Jennifer Tiffany-Amaro, Janet Thomas, Erika Vucko, Leah B. Wessenberg, Kaleigh Whitehall

• Publication

Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)

Janet Thomasa, Harvey Levy, Stephen Amato, Jerry Vockley, Roberto Zori, David Dimmock, Cary O. Harding, Deborah A. Bilder, Haoling H. Weng, Joy Olbertz, Markus Merilainen, Joy Jiang, Kevin Larimore, Soumi Gupta, Zhonghua Gu, Hope Northrup, on behalf of the PRISM investigators

• Publication

Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial

Cary O. Harding, R. Stephen Amato, Mary Stuy, Nicola Longo, Barbara K. Burtone, John Posner, Haoling H. Weng, Markus Merilainen, Zhonghua Gu, Joy Jiang, Jerry Vockley, on behalf of the PRISM-2 Investigators

• Publication

Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data

Fran Rohr, Barbara Burton, Anne Dee, Cary O. Harding, Joshua Lilienstein, Kristin Lindstrom, Erin MacLeod, Sarah Rose, Rani Singh, Sandra van Calcar, Kaleigh Whitehall

• Page

Global Medical Information Form

• Page

Reporting a Product Complaint

• Page

Report an Adverse Event

• Page

PKU

• Board Profile

Athena Countouriotis

• Board Profile

Mark Enyedy

• Board Profile

Alexander Hardy

• Leadership Profile

Cristin Hubbard

• Leadership Profile

Greg Friberg